Citation: Os. Gudmundsson, Additional transporter characterization may lead to new pharmaceutical opportunities, PHARM RES, 18(11), 2001, pp. 1481-1482
Authors:
Gudmundsson, OS
Jois, SDS
Vander Velde, DG
Siahaan, TJ
Wang, B
Borchardt, RT
Citation: Os. Gudmundsson et al., The effect of conformation on the membrane permeation of coumarinic acid- and phenylpropionic acid-based cyclic prodrugs of opioid peptides, J PEPT RES, 53(4), 1999, pp. 383-392
Authors:
Bak, A
Siahaan, TJ
Gudmundsson, OS
Gangwar, S
Friis, GJ
Borchardt, RT
Citation: A. Bak et al., Synthesis and evaluation of the physicochemical properties of esterase-sensitive cyclic prodrugs of opioid peptides using an (acyloxy)alkoxy linker, J PEPT RES, 53(4), 1999, pp. 393-402
Authors:
Gudmundsson, OS
Vander Velde, DG
Jois, SDS
Bak, A
Siahaan, TJ
Borchardt, RT
Citation: Os. Gudmundsson et al., The effect of conformation of the acyloxyalkoxy-based cyclic prodrugs of opioid peptides on their membrane permeability, J PEPT RES, 53(4), 1999, pp. 403-413
Authors:
Gudmundsson, OS
Pauletti, GM
Wang, W
Shan, DX
Zhang, HJ
Wang, BH
Borchardt, RT
Citation: Os. Gudmundsson et al., Coumarinic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeability, PHARM RES, 16(1), 1999, pp. 7-15
Authors:
Gudmundsson, OS
Nimkar, K
Gangwar, S
Siahaan, T
Borchardt, RT
Citation: Os. Gudmundsson et al., Phenylpropionic acid-based cyclic prodrugs of opioid peptides that exhibitmetabolic stability to peptidases and excellent cellular permeation, PHARM RES, 16(1), 1999, pp. 16-23
Authors:
Bak, A
Gudmundsson, OS
Friis, GJ
Siahaan, TJ
Borchardt, RT
Citation: A. Bak et al., Acyloxyalkoxy-based cyclic prodrugs of opioid peptides: Evaluation of the chemical and enzymatic stability as well as their transport properties across Caco-2 cell monolayers, PHARM RES, 16(1), 1999, pp. 24-29